Retail Pharmacies Take Big Hit After Amazon's PillPack Deal

The day the retail giant announced plans to acquire the online pharmacy company PillPack, competing retail pharmacy companies took a significant blow. Eight companies, including CVS and Rite Aid, dropped $17.5 billion in market cap in just one day. For full interview, [click here](https://cheddar.com/videos/amazon-acquisition-of-pillpack-crushes-shares-of-walgreens-cvs-rite-aid).

More In Business

How Augury Is Powering Fortune 500s With AI Infrastructure

Saar Yoskovitz, CEO of Augury, shares how the company delivers AI infrastructure that Fortune 500s rely on to boost efficiency, reliability, and scale.

How Webtoon Is Leading Digital Comics – Inside What’s Next

David Lee, COO & CFO of Webtoon, shares insights on the company’s earnings, global growth, and how AI is shaping the future of digital storytelling.

How Kim Perell Turned Mistakes into Millions

Entrepreneur & author Kim Perell shares lessons from 'Mistakes That Made Me a Millionaire', revealing how failure was the key to building her success.

Big Business This Week: Is the U.S. economy entering its weird era?

The U.S. economy is in a strange place.

From Trade Tensions to Rate Cuts: What’s Driving the Market Now?

Mark Hackett, Chief Market Strategist at Nationwide, shares insight on market sentiment, Fed policy impact, and the outlook amid trade tensions.

Crypto 401(k)s Explained: Maple CEO Sid Powell on the Staking Revolution

Sid Powell, CEO of Maple Finance, demystifies crypto 401(k)s and explains how staking lets users earn passive yield while supporting decentralization.

Bullish IPO Soars: An Inside View with President Chris Tyrer

Chris Tyrer, President at Bullish (NYSE: BLSH), reveals how the IPO-fueled rise of the company is redefining institutional crypto markets.

Inside the Pricey White House Upgrade No One Saw Coming

Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.

Is RFK Jr. Halting Progress? The Fallout of Cutting mRNA Vaccine Research

Dr. Richard Besser, President & CEO of the Robert Wood Johnson Foundation and former CDC acting director, unpacks the impact of RFK's mRNA funding cuts.

Volatility Incoming? What the Latest Earnings Are Telling Us

Jessica Inskip, Director of Investor Research at StockBrokers.com and host of MarketMakeHer, unpacks earnings, market outlook, and what history says is next.

Load More